KRTX - Karuna Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $366.17. This is a potential upside of $36.34 (11.02%) from yesterday's end of day stock price of $329.83.

Karuna Therapeutics's activity chart (see below) currently has 182 price targets and 119 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.56% with an average time for these price targets to be met of 202.09 days.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 11-Mar-2024. First documented stock forecast 23-Jul-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Dec-2023

$330

$0.17 (0.05%)

$330

2 years 10 days ago
(11-Mar-2024)

13/15 (86.67%)

$10.81 (3.39%)

281

Hold Since 08-Mar-2023

$330

$0.17 (0.05%)

$330

2 years 1 months 1 days ago
(20-Feb-2024)

2/4 (50%)

$11.41 (3.58%)

86

Hold Since 26-Jan-2024

$245

$-84.83 (-25.72%)

$245

2 years 1 months 23 days ago
(26-Jan-2024)

12/13 (92.31%)

$-69 (-21.97%)

168

Hold Since 22-Dec-2023

$227

$-102.83 (-31.18%)

$227

2 years 2 months 27 days ago
(22-Dec-2023)

5/6 (83.33%)

$-90.85 (-28.58%)

177

Buy Since 20-Jul-2023

$295

$-34.83 (-10.56%)

$280

2 years 2 months 27 days ago
(22-Dec-2023)

2/3 (66.67%)

$-22.85 (-7.19%)

148

Show more analysts

Please expand the browser size to see the chart

What is KRTX (Karuna Therapeutics) average time for price targets to be met?

On average it took 202.09 days on average for the stock forecasts to be realized with a an average price target met ratio 92.56

Which analyst has the current highest performing score on KRTX (Karuna Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on KRTX (Karuna Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on KRTX

Which analyst is the currently most bullish on KRTX (Karuna Therapeutics)?

Charles Duncan with highest potential upside - $0.17

Which analyst is the currently most reserved on KRTX (Karuna Therapeutics)?

Liana Moussatos with lowest potential downside - -$195.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?